Introduction {#s1}
============

HIV-related stigma remains one of the greatest barriers to the health and well being of people living with HIV (PLHIV) [@pone.0048168-Herek1], [@pone.0048168-UNAIDS1]. HIV-related stigma refers to the devaluing of HIV-positive people, and may result in discrimination based on actual or perceived HIV-positive serostatus [@pone.0048168-UNAIDS1]. HIV-related stigma may exacerbate pre-existing social inequities based on race, class, gender, and sexual orientation [@pone.0048168-Parker1], [@pone.0048168-Sumartojo1]. It is particularly important to understand the interactions of HIV-related stigma with race and gender as HIV infections are rising among women globally and there is an overrepresentation of new HIV infections among Black and Aboriginal people in Canada [@pone.0048168-Public1], [@pone.0048168-UNAIDS2].

Prior research with PLHIV has indicated that HIV-related stigma is associated with deleterious mental, psychological, and emotional health outcomes [@pone.0048168-Berger1]--[@pone.0048168-Ware1]. HIV-related stigma may also compromise treatment, care and support for PLHIV. Disclosure of one\'s HIV positive serostatus to friends, family, social support networks and health care providers has been associated with marginalization, isolation and social exclusion [@pone.0048168-Vanable1], [@pone.0048168-Abell1], [@pone.0048168-Kymla1]. Fear of disclosure associated with purchasing and taking antiretroviral drugs may negatively impact treatment adherence [@pone.0048168-Ware1], [@pone.0048168-KonkleParker1]--[@pone.0048168-Rintamaki1]. Thus HIV-related stigma may lead to sub-standard treatment and can also present a barrier for PLHIV accessing and retaining health care services and social supports [@pone.0048168-Bradford1]--[@pone.0048168-White1]. Reducing HIV-related stigma is therefore key to promoting the health of PLHIV.

Understanding and reducing HIV-related stigma, however, is complicated by its intersection with cross-cultural differences, structural inequalities, and social processes [@pone.0048168-Parker1], [@pone.0048168-Campbell1]--[@pone.0048168-VanBrakel1]. Also, there remains a gap in understanding how HIV-related stigma interacts with socio-demographic factors such as gender and ethnicity [@pone.0048168-Logie1], [@pone.0048168-Lee1]. In a meta-analysis of demographic correlates of HIV-related stigma among PLHIV in North America, only 2 out of 24 studies examined ethnicity and 3 examined gender [@pone.0048168-Logie1]. This study highlighted contradictory findings regarding the associations between HIV-related stigma and race/ethnicity [@pone.0048168-Logie1]--[@pone.0048168-Schuster1] and gender [@pone.0048168-Lee1], [@pone.0048168-Emlet1], [@pone.0048168-Steward1]--[@pone.0048168-Emlet2]. This area therefore warrants further exploration.

Stigma analyses are also complicated by the myriad types of stigma, including perceived, internalized, enacted, layered/compounded, and symbolic. Perceived stigma refers to awareness of negative societal attitudes, fear of discrimination and feelings of shame [@pone.0048168-Berger1], [@pone.0048168-Herek2]--[@pone.0048168-Meyer1]. Internalized stigma refers to an individual\'s acceptance of negative beliefs, views and feelings towards the stigmatized group they belong to and oneself [@pone.0048168-Herek3], [@pone.0048168-Mak1]--[@pone.0048168-Kalichman1]. Enacted stigma encompasses overt acts of discrimination, such as violence and exclusion [@pone.0048168-Herek2], [@pone.0048168-Nyblade1]. Layered or compounded stigma refers to a person holding more than one stigmatized identity, for example a gay PLHIV who faces stigma associated with HIV as well as sexual orientation [@pone.0048168-Nyblade1]--[@pone.0048168-Sengupta1]. Symbolic HIV-related stigma refers to blaming and judging already stigmatized groups for causing, spreading and perpetuating the HIV epidemic [@pone.0048168-Herek2], [@pone.0048168-Deacon1]--[@pone.0048168-Herek5].

This study was guided by the theoretical concept of intersectionality. Intersectionality refers to the interdependent relationships between social identities (e.g. gender, race/ethnicity) and social inequities (e.g. sexism, racism) [@pone.0048168-Vanable2]--[@pone.0048168-Crenshaw1]. Intersectional perspectives conceptualize that the convergence of different identities (e.g. gender, race/ethnicity) produces distinct and different experiences of inequity and opportunity [@pone.0048168-Vanable2], [@pone.0048168-Collins2]--[@pone.0048168-PurdieVaughns1]. Intersectionality has been used as a guiding theoretical framework for HIV research in the United States (U.S.) and the United Kingdom (U.K.): these studies revealed that race and gender shaped PLHIV\'s experiences of HIV-related stigma [@pone.0048168-Collins3]--[@pone.0048168-Margulies1]. Qualitative research in Canada suggests that HIV prevention barriers among Black women include sexism, racism and HIV-related stigma [@pone.0048168-Newman1]--[@pone.0048168-Logie2], underscoring the salience of working from an intersectional approach.

The objective of this study was to understand the associations between gender, ethnicity and HIV-related stigma among PLHIV in Ontario, Canada. The secondary objective was to explore associations between HIV-related stigma and other demographic and clinical variables. A clear understanding of the associations between HIV-related stigma, gender and ethnicity can inform the development, implementation and evaluation of tailored stigma reduction interventions [@pone.0048168-Nyblade1], [@pone.0048168-Deacon1], [@pone.0048168-Link1].

Methods {#s2}
=======

Ethical Considerations {#s2a}
----------------------

Written informed consent was obtained from all participants in the OCS. This study was approved by the OHTN Governance Committee and the University of Toronto Research Ethics Board. Research methods for this study were conducted following the principles of the Helsinki Declaration.

Study Design and Population {#s2b}
---------------------------

The study was a cross-sectional analysis using the baseline visit of the prospective observational study, the Ontario HIV Treatment Network (OHTN) Cohort Study (OCS) [@pone.0048168-Rourke1]. The OCS is a multi-site, clinical and population health prospective observational research study that recruited participants through primary and tertiary care sites. Clinical data was collected from multiple sources including electronic medical records, chart abstraction and linkages to other laboratory databases. In October 2007, the OCS introduced an annual interviewer-administered questionnaire which was either a 20-minute core questionnaire or a 90-minute extended questionnaire providing extensive socio-behavioural and demographic information [@pone.0048168-Rourke1]. For this analysis, only those completing the extended questionnaire which includes the HIV-related Stigma Scale were included. The current analysis included participants recruited from October 2007 to September 2009. Four clinic sites recruited for the OCS extended questionnaire during that time period and all were tertiary hospital clinics in Toronto. Sampling was non-random and targeted to those enrolled in a prior cohort and harder-to-reach populations including women, heterosexual men, those born in countries with a high prevalence of HIV, Aboriginal individuals, those with recent infection and injection drug users [@pone.0048168-Rourke1]. Additional detail on sampling and recruitment is available in a prior publication [@pone.0048168-Rourke1]. Refusal rates were approximately from 5% to 20% and varied by clinic [@pone.0048168-Raboud1].

Inclusion criteria for this analysis were that participants must: 1) be HIV positive based on a positive HIV antibody test or other laboratory evidence of HIV infection; 2) have provided OCS data on gender; 3) must have completed the OCS HIV-related Stigma Scale.

Measuring HIV-related Stigma {#s2c}
----------------------------

Stigma outcomes were measured using a revised shorter version of the HIV Stigma Scale developed by Berger and colleagues [@pone.0048168-Berger2], [@pone.0048168-Gibson1]. The 16-item stigma questionnaire has four subscales: "Personalized Stigma" (enacted stigma), "Disclosure Concerns" (enacted stigma), "Negative Self-Image" (internalized stigma), and "Concern with Public Attitudes" (perceived stigma) [@pone.0048168-Berger2]. Each subscale contained four items on a 5-point Likert scale. The total stigma score was calculated by summing the scores for the four subscales; missing values were imputed. The total HIV Stigma score ranges from 16 to 80, with higher scores indicating a higher degree of HIV-related stigma.

Definition of Correlates {#s2d}
------------------------

The primary study outcomes were comparisons of severity and prevalence of HIV-related stigma by gender and ethnicity. For the comparative analyses of gender, only participants identifying as men or women were included. Due to the small number of participants (n = 9) self-identifying as transsexual, transgender or inter-sexed, these responses were excluded from the analysis.

Participants were assigned to an ethnicity category based on self-reported answer to the question "How would you describe your ethnicity?" Response options included White, Black, Latin American, South Asian, South East Asian, Arab/West Indian, Aboriginal, other, don\'t know, and refuse to answer. Participants were then sub-categorized into Black, White, Aboriginal, and Asian/Latin-American/Unspecified for the analyses.

Other HIV-related stigma correlates were assessed by examining associations with demographic and clinical variables including: age, HIV risk factors, sexual orientation, country of origin, immigration status, rural/urban residence, education, employment status, housing status, personal income, alcohol and drug use, duration of HIV diagnosis, CD4 count, viral load, and antiretroviral adherence.

Statistical Analysis {#s2e}
--------------------

Baseline demographic information, clinical characteristics, and HIV-related stigma scores were tabulated by gender (male vs. female). Categorical variables were summarized with frequencies and proportions and compared between groups using chi-square tests or Fisher\'s exact test. Continuous variables were summarized with medians and inter-quartile ranges (IQR) and compared between groups using Wilcoxon Rank Sum tests. Types of HIV-related stigma types were examined by tabulating the subscale scores by gender and by ethnicity within gender.

Linear regression models were used to determine the estimates of total stigma scores associated with gender and ethnicity after adjusting for other covariates. Covariates which were significant in univariate models with a significance level \<0.10 or which were a priori believed to be associated with HIV-related stigma were considered as candidates for inclusion in the multivariate logistic regression model. Covariates that were considered included variables such as: age, duration of HIV infection, injection drug use (IDU), HIV risk factors, country of origin, immigration status, education, employment status, housing status, and personal income. These statistical analyses were performed using SAS Statistical Software Version 9.2 by SAS Institute Inc., Cary, NC, USA.

Results {#s3}
=======

Cohort Characteristics {#s3a}
----------------------

Of the 1073 participants who completed the extended questionnaire as of November, 2009, 1035 met the inclusion criteria (38 participants were excluded as there was not enough data to calculate a total stigma score). Of these respondents, nine self-identified as transgender or inter-sexed. Seven of the nine transgender individuals were transwomen (n = 7); their median age was 46 (IQR 44--50). Cohort characteristics of the remaining 1026 participants, grouped by gender, are summarized in [Table 1](#pone-0048168-t001){ref-type="table"}. There were significant differences between men and women in age, HIV risk factors, sexual orientation, ethnicity, country of origin, immigration status, years since immigration, and years since HIV diagnosis. Men were more likely to be: an older age (\[median IQR\] 48 years old [@pone.0048168-Reidpath1]--[@pone.0048168-Doyal1] vs. 41 years old [@pone.0048168-Emlet2]--[@pone.0048168-Crenshaw1], p\<0.0001), White (68% vs. 34%, p\<0.0001), and gay/bisexual (81% vs. 5%, p\<0.0001). Men also had a longer duration of HIV infection (12 years vs. 8 years, p\<0.0001).

10.1371/journal.pone.0048168.t001

###### Demographic and Clinical Characteristics by Gender.

![](pone.0048168.t001){#pone-0048168-t001-1}

  Variable                                           Total n = 1026   Female n = 167    Male n = 859    P-value (F vs M)
  ------------------------------------------------- ---------------- ---------------- ---------------- ------------------
  Age (at time of Questionnaire)                      47 (41--53)      41 (34--49)      48 (42--54)         \<.0001
  Risk Factor (not mutually exclusive)                                                                 
  MSM                                                 698 (68.0%)           \-          698 (81.3%)            \-
  IDU                                                  69 (6.7%)        10 (6.0%)        59 (6.9%)            0.68
  Heterosexual contact                                304 (29.6%)      161 (96.4%)      143 (16.6%)         \<.0001
  Blood product/Other                                  88 (8.6%)        21 (12.6%)       67 (7.8%)            0.04
  Lesbian/Gay/Bisexual                                702 (68.8%)        8 (4.8%)       694 (81.3%)         \<.0001
  Race/Ethnicity                                                                                       
  White                                               641 (62.5%)       57 (34.1%)      584 (68.0%)         \<.0001
  Black/African                                       170 (16.6%)       84 (50.3%)       86 (10.0%)    
  Aboriginal                                           60 (5.8%)         8 (4.8%)        52 (6.1%)     
  Asian/Latin-American/Unspecified                    155 (15.1%)       18 (10.8%)      137 (15.9%)    
  Country of Origin                                                                                    
  Canada                                              614 (59.9%)       58 (34.9%)      556 (64.7%)         \<.0001
  High HIV-prevalent country (Endemic)                195 (19.0%)       87 (52.4%)      108 (12.6%)    
  Non-Endemic                                         216 (21.1%)       21 (12.7%)      195 (22.7%)    
  Immigration Status                                                                                   
  Canadian-Born                                       614 (59.9%)       58 34.9%)       556 (64.7%)         \<.0001
  Canadian Citizen                                    305 (29.8%)       68 (41.0%)      237 (27.6%)    
  Landed/Permanent Resident                            72 (7.10%)       27 (16.3%)       45 (5.2%)     
  Other                                                34 (3.3%)        13 (7.8%)        21 (2.4%)     
  Years since Immigration                             22 (12--32)       12 (7--22)      22 (12--37)         \<.0001
  Education                                                                                            
  Less than High School                               129 (12.6%)       29 (17.4%)      100 (11.6%)          \<.01
  Completed High School                               192 (18.7%)       35 (21.0%)      157 (18.3%)    
  Some college/technical school/university            180 (17.5%)       23 (13.8%)      157 (18.3%)    
  Completed college/technical school                  228 (22.2%)       49 (29.3%)      179 (20.8%)    
  Completed university/Post-graduate                  297 (28.9%)       31 (18.6%)      266 (31.0%)    
  Employment Status                                                                                    
  Employed FT/PT                                      481 (47.0%)       77 (46.1%)      404 (47.1%)           0.25
  Student/Retired/Disability                          454 (44.3%)       70 (41.9%)      384 (44.8%)    
  Unemployed                                           89 (8.7%)        20 (12.0%)       69 (8.1%)     
  Personal Income \< \$20,000/year                    425 (42.2%)       81 (50.0%)      344 (40.7%)           0.03
  Live in Toronto                                     791 (80.8%)      117 (76.0%)      674 (81.7%)           0.11
  Housing                                                                                              
  House/Apartment/Condo                               986 (96.3%)      161 (96.4%)      825 (96.3%)           0.39
  Room/Housing Facility                                30 (2.9%)         6 (3.6%)        24 (2.8%)     
  Homeless                                              8 (0.8%)         0 (0.0%)         8 (1.0%)     
  Alcohol/Drug Use                                                                                     
  Never                                               272 (26.5%)       66 (39.5%)      206 (24.0%)         \<.0001
  Monthly or less                                     243 (23.7%)       53 (31.7%)      190 (22.1%)    
  2--4 times a month                                  233 (22.7%)       30 (18.0%)      203 (23.6%)    
  2--3 times a week                                   139 (13.5%)       13 (7.8%)       126 (14.7%)    
  4 or more times a week                              139 (13.5%)      \<6 (\<3.6%)     134 (15.6%)    
  Any cannabis in the last 12 months                   367 (35%)        32 (19.2%)      335 (39.1%)         \<.0001
  Any non-medicinal drug use in the last 6 months     171 (16.7%)       13 (7.8%)       158 (18.4%)          \<.01
  Clinical Characteristics                                                                             
  Years since HIV diagnosis                            12 (6--17)       8 (5--14)        12 (6--17)         \<.0001
  CD4 cell count                                     460 (317--637)   474 (300--665)   456 (318--632)         0.76
  Undetectable Viral Load                             766 (74.7%)      116 (69.5%)      650 (75.7%)           0.09
  Any AIDS defining condition                         367 (35.8%)       64 (38.3%)      303 (35.3%)           0.45
  Hepatitis B                                         107 (10.4%)       11 (6.6%)        96 (11.2%)           0.08
  Hepatitis C                                          63 (6.1%)         8 (4.8%)        55 (6.4%)             3
  ARV Use/Adherence                                                                                    
  No ARV                                              141 (13.8%)       37 (22.2%)      104 (12.2%)          \<.001
  On ARV: No missed doses                             754 (73.8%)      107 (64.1%)      647 (75.8%)    
  On ARV: Missed at least 1 dose in past 4 days.      126 (12.3%)       23 (13.8%)      103 (12.1%)    

*Footnote.* MSM  =  men who have sex with men, IDU  =  injection drug use, employed FT/PT  =  employed full-time/part-time, ARV  =  antiretroviral.

Total Stigma and Subscale Scores by Gender {#s3b}
------------------------------------------

The total and subscale stigma scores analyzed by gender are summarized in [Table 2](#pone-0048168-t002){ref-type="table"}. Women had significantly higher median total stigma scores and scores across all four subscales than men.

10.1371/journal.pone.0048168.t002

###### Total Stigma Scores and Subscale Scores by Gender.
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  *Variables*                                   *Total n = 1026*   *Female n = 167*   *Male n = 859*   *P value*
  -------------------------------------------- ------------------ ------------------ ---------------- -----------
  Personalized Stigma (Enacted)                    10 (8--14)         12 (8--16)        9 (7--14)       \<.0001
  Disclosure (Enacted)                            15 (12--18)        16 (15--19)       15 (11--17)      \<.0001
  Concerns with Public Attitudes (Perceived)      13 (10--15)        15 (12--17)       12 (10--15)      \<.0001
  Negative Self-Image (Internalized)              15 (12--18)        16 (15--19)       15 (11--17)      \<.0001
  Total                                           49 (40--57)        56 (48--64)       48 (39--56)      \<.0001

*Footnote.* Each subscale score is calculated by adding up the score from the relevant questions, with a score range of 4 -- 20. The total stigma score is calculated by adding up the subscale scores, with a score range of 16 -- 80. Higher scores indicate a higher degree of HIV-related stigma.

Comparison of Stigma Scores Across Ethnicities by Gender {#s3c}
--------------------------------------------------------

Among women, White women had lower median total stigma scores than Black, Aboriginal, and Asian/Latin-American/Unspecified women ([Table 3](#pone-0048168-t003){ref-type="table"}). These differences were influenced by differences between ethnicities in the "Concern with Public Attitudes" subscale: Black women had significantly higher scores on this subscale than Aboriginal, Asian/Latin-American/Unspecified and White women ([Table 3](#pone-0048168-t003){ref-type="table"}). There were no significant differences in the subscale scores for "Personalized Stigma", "Disclosure Concerns", and "Negative Self-Image" across all four ethnicities for female participants ([Table 3](#pone-0048168-t003){ref-type="table"}).

10.1371/journal.pone.0048168.t003

###### Total Stigma Scores and Subscale Scores by Female Gender and Ethnicity.
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  *Women*                          *White n = 57*   *Black or African n = 84*   *Aboriginal n = 8*   *Other n = 18*   *p-value*
  ------------------------------- ---------------- --------------------------- -------------------- ---------------- -----------
  Personalized (Enacted) Stigma      11 (8--16)            12 (10--16)             12 (8--13.5)        10 (8--16)       0.37
  Disclosure Concerns               16 (15--19)            17 (15--19)            16 (15.5--17)      16.5 (15--19)      0.79
  Concern with Public Attitudes     13 (11--15)            16 (14--18)           14.8 (11.5--16)      15 (12--19)       \<001
  Negative Self Image                11 (9--15)           14 (10.5--16)             12 (8--17)         14 (8--15)       0.34
  Total                             53 (45--60)           57.5 (53--65)           55.3 (50.5--60     54.5 (47--66)      0.02

*Footnote.* Each subscale score is calculated by adding up the score from the relevant question, with a score range of 5 -- 20. The total stigma score is calculated by adding up the subscale scores, with a score range of 16 -- 80. Higher scores indicate a higher degree of HIV-related stigma.

Black men had significantly higher total stigma scores than Aboriginal, Asian/Latin-American/Unspecified, and White men. There were also similar significant differences across all four subscales ([Table 4](#pone-0048168-t004){ref-type="table"}). Black men had the highest total stigma and the highest stigma for each subscale except Personalized Stigma, for which Aboriginal men had the highest levels.

10.1371/journal.pone.0048168.t004

###### Total Stigma Scores and Subscale Scores by Male Gender and Ethnicity.
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  *Men*                            *White n = 584*   *Black or African n = 86*   *Aboriginal n = 52*   *Other n = 137*   *p-value*
  ------------------------------- ----------------- --------------------------- --------------------- ----------------- -----------
  Personalized (Enacted) Stigma       9 (7--13)             11 (8--15)               12 (8--15)         10.7 (8--15)      \<.0001
  Disclosure Concerns                14 (11--17)            16 (12--18)              15 (11--18)         15 (12--18)       \<.01
  Concern with Public Attitudes      12 (10--14)           14.3 (12--16)            12.5 (10--15)       13.3 (11--16)     \<.0001
  Negative Self Image                10 (8--14)             11 (8--16)             10 (8.5--14.5)        11 (8--15)        \<.01
  Total                              46 (38--54)           53.5 (42--62)             51 (40--57)        51.7 (42--60)     \<.0001

*Footnote.* Each subscale score is calculated by adding up the score from the relevant question, with a score range of 5 -- 20. The total stigma score is calculated by adding up the subscale scores, with a score range of 16 -- 80. Higher scores indicate a higher degree of HIV-related stigma.

Linear Regression Analysis of Total Stigma Scores {#s3d}
-------------------------------------------------

For modelling purposes, ethnicities were divided into 3 groups: White, Black and Aboriginal/Asian, Latin-American/Unspecified. Significant correlates associated with higher total stigma scores in the univariate regression analysis were female gender, non-White race, heterosexual contact or contaminated blood contact and unspecified HIV risk factor, origin from a country with high HIV prevalence, non-Canadian-born immigration status, low income, and living outside of an urban area (Toronto) ([Table 5](#pone-0048168-t005){ref-type="table"}). Older age, longer duration of HIV diagnosis, lesbian gay bisexual (LGB) sexual orientation, higher education, men who have sex with men (MSM) HIV risk factor, and more frequent alcohol use, marijuana use in the last 12 months, and any non-medicinal drug use in the last 6 months were associated with lower total stigma scores in the univariate model.

10.1371/journal.pone.0048168.t005

###### Univariate and Multivariable Linear Regression Models with Outcomes of Total Stigma Scores.
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                                                                   *Univariate*   *Multivariable (n = 970)*              
  --------------------------------------------------------------- -------------- --------------------------- ----------- ---------
  Gender                                                                                                                 
  Male                                                              Reference                                            
  Female                                                               8.05                \<.0001                       
  Race/Ethnicity                                                                                                         
  White                                                             Reference                                            
  Black or African                                                     8.65                \<.0001                       
  Aboriginal/Asian, Latin-American/Unspecified                         4.15                \<.0001                       
  Gender \* Race/Ethnicity                                                                                               
  White Male                                                        Reference                                 Reference  
  Black or African Male                                                6.19                \<.0001              2.76       0.06
  Aboriginal/Asian, Latin- American/Unspecified Ethnicity Male         4.19                \<.0001              2.83       \<.01
  White Female                                                         6.18                \<.001               1.63       0.37
  Black or African Female                                             12.27                \<.0001              5.93      \<.001
  Aboriginal/Asian, Latin-American/Unspecified Ethnicity Female        8.40                \<.001               1.83       0.45
  Age (per 10 years)                                                  −2.86                \<.0001              −1.42     \<.001
  Risk Factor (not mutually exclusive)                                                                                   
  MSM                                                                 −7.97                \<.0001                       
  IDU                                                                  0.93                 0.54                         
  Heterosexual contact                                                 8.30                \<.0001                       
  Other\*                                                              4.17                 \<.01               3.08       0.02
  Lesbian/Gay/Bisexual                                                −7.89                \<.0001              −4.06     \<.0001
  Country of Origin                                                                                                      
  Canada                                                            Reference                                            
  Endemic                                                              9.09                \<.0001                       
  Non-Endemic                                                          3.38                \<.001                        
  Immigrant Status                                                                                                       
  Canadian-Born                                                     Reference                                            
  Canadian Citizen                                                     5.35                \<.0001                       
  Landed/Permanent Resident                                            7.81                \<.0001                       
  Other                                                                9.12                \<.0001                       
  Residence                                                                                                              
  Toronto                                                           Reference                                            
  Other GTA/Ontario                                                    2.46                  .01                2.57       \<.01
  Education                                                                                                              
  Less than High School                                             Reference                                            
  Complete HS                                                         −2.59                 0.06                −2.94      0.02
  College or University                                               −3.76                 \<.01               −3.46      \<.01
  Employment Status                                                                                                      
  Full/Part Time                                                    Reference                                            
  Student/Retired/Disability                                          −0.16                 0.84                         
  Unemployed                                                           2.81                 0.05                         
  Room/Housing Facility/Homeless                                       0.08                 0.97                         
  Personal Income \< \$20,000 per year                                 2.29                 \<.01                        
  Alcohol/Drug Use                                                                                                       
  Alcohol Frequency                                                                                                      
  Never or Less than Monthly                                        Reference                                            
  More than Monthly                                                   −3.06                \<.0001              −1.49      0.04
  Any cannabis use in last 6 months                                   −2.25                 \<.01                        
  Any non-medicinal drugs in last 6 months                            −2.29                  .02                         
  Clinical Characteristics                                                                                               
  Years since HIV diagnosis                                           −3.95                \<.0001              −1.94      \<.01
  CD4 cell count (per 100 cells/mm^3^)                                −0.21                 0.13                         
  Undetectable Viral Load                                             −1.04                 0.24                         
  Any AIDS defining condition                                         −0.21                 0.79                         
  Hepatitis B                                                         −0.91                 0.46                         
  Hepatitis C                                                         −0.83                 0.60                         
  ARV/Adherence                                                                                                          
  Not on ARV                                                        Reference                                            
  No missed doses in 4 days                                           −1.81                 0.10                         
  Missed dose in last 4 days                                          −0.21                 0.89                         

*Footnote.* MSM  =  men who have sex with men, IDU  =  injection drug use, HS  =  high school, GTA  =  Greater Toronto Area, ARV  =  antiretroviral. \*Other Risk Factors  =  contaminated blood contact or unspecified risk.

In the multivariate model, we examined the effect of gender and ethnicity simultaneously using an interaction term with the reference group (White male); in the final model, HIV-related scores for Aboriginal/Asian/Latin-American/Unspecified men and Black women were significantly higher than White men; and nearly significant for Black men. Residence outside of the urban area and contaminated blood contact or unspecified HIV risk factor were also associated with higher stigma scores. Correlates of lower stigma included older age, longer duration since HIV diagnosis, LGB sexual orientation, higher education level, and more frequent alcohol use ([Table 5](#pone-0048168-t005){ref-type="table"}).

Discussion {#s4}
==========

In this study female gender and non-White ethnicity were consistently associated with higher total and subscale HIV-related stigma scores. Gender and ethnicity interacted to increase the degree of stigma experienced: Black women, Aborginal/Asian/Latin-American/Unspecified men, and Black men reported the highest HIV-related stigma. Lower HIV-related stigma was associated with older age, time since diagnosis, LGB sexual orientation, higher education and alcohol frequency. Overall, findings suggest that HIV-related stigma may exacerbate certain pre-existing social inequities based on race and gender. Yet there may not be a clear-cut relationship between marginalization and HIV-related stigma: sexual minorities experienced lower HIV-related stigma than heterosexuals, and drug users reported lower rates of stigma than non-drug users.

Experiences of high levels of HIV-related stigma among women in this study, in particular Black women, suggests that sexist and racist stereotypes continue to permeate HIV discourse [@pone.0048168-Farmer1]--[@pone.0048168-Wolffers1]. HIV-positive women have been positioned as "dirty, diseased and undeserving" [@pone.0048168-Lawless1] and may be blamed and shamed for HIV infection due to lasting assumptions of "deviant" sexual behaviour (e.g. sex work, promiscuity) [@pone.0048168-Lekas1], [@pone.0048168-Sandelowski1], [@pone.0048168-Sowell1], [@pone.0048168-Link1], [@pone.0048168-Wolffers1], [@pone.0048168-Katz1]. Gender norms that construct women as caregivers, mothers and nurturers can exacerbate stigma directed toward HIV-positive women who may be viewed as ill/diseased and therefore a failure in personal and social roles [@pone.0048168-Swendeman1], [@pone.0048168-Lawless1], [@pone.0048168-Green1], [@pone.0048168-Ingram1]. The intersection of gender, race/ethnicity and class oppression are integral to understanding contexts of women\'s HIV risk and experiences of stigma [@pone.0048168-Logie2], [@pone.0048168-Amaro1].

Racist stereotypes have been entrenched within constructions of HIV since the epidemic\'s beginning, with HIV constructed as first a "Haitian" and later an "African" disease [@pone.0048168-Farmer1], [@pone.0048168-Gilman1], [@pone.0048168-Patton1]. HIV discourse has promoted racial stereotypes of ethnic minorities, in particular Black populations, as promiscuous, dangerous, and a threat to society [@pone.0048168-Farmer1], [@pone.0048168-Patton1]. Higher HIV-related stigma among ethnic minorities and Aboriginal PLHIV in comparison with White PLHIV, found in this study, has also been reported in previous studies [@pone.0048168-Emlet1], [@pone.0048168-Newman2] and reveals the embeddedness of racist stereotypes in HIV-related stigma [@pone.0048168-Lekas1]. Activism surrounding HIV and (homo)sexuality may have reduced HIV-related stigma among some LGBQ communities, yet there does not appear to be the same history of activism or success in challenging racist and sexist stereotypes ingrained in HIV discourse [@pone.0048168-Farmer1], [@pone.0048168-Patton1]. In light of the growing HIV infection rates among Black and Aboriginal communities in Canada, in particular among Black and Aboriginal women, [@pone.0048168-Public1] such findings underscore the salience of challenging sexist and racist stereotypes.

Since the beginning of the epidemic, HIV and AIDS have been associated with "deviant sexuality" (e.g. homosexuality, sex work) -- reinforcing the notion of the disease as punishment [@pone.0048168-Farmer1]--[@pone.0048168-Patton1], [@pone.0048168-Cloete1]. Challenging homophobia and HIV-related stigma have been central components of lesbian, gay, bisexual, and queer (LGBQ) community mobilization and activism in North America, Western Europe and Australia since the early 1980\'s \[68, -69\]. The present study\'s finding that sexual minorities experience lower HIV-related stigma than heterosexuals suggests that such activism may have been successful in reducing the associations between "deviance", homosexuality and HIV, and in creating safe places within urban LGBQ communities for PLHIV in Canada. Higher levels of HIV-related stigma among heterosexuals than sexual minorities have been reported in other studies, perhaps also due to concerns of heterosexual PLHIV being perceived as a sexual minority and/or fears of homophobia [@pone.0048168-Logie1], [@pone.0048168-Lee1], [@pone.0048168-Herek4].

Drug use was associated with lower HIV-related stigma in this analyis. There are conflicting findings regarding drug use and stigma: some authors suggest drug use is a factor that exacerbates HIV-related stigma [@pone.0048168-Mahajan1], [@pone.0048168-Reidpath1], while others have found drug use is correlated with lower HIV-related stigma among PLHIV [@pone.0048168-Swendeman1]. Drug users may have developed coping mechanisms related to drug use to decrease stigma [@pone.0048168-Swendeman1], and may also perceive lower HIV-related stigma due to to greater concerns regarding drug use stigma [@pone.0048168-Goffman1].

Other factors associated with lower HIV-related stigma in the current study--urban residence, older age and higher levels of education--corroborate previous research [@pone.0048168-Heckman1], [@pone.0048168-Logie1], [@pone.0048168-Reif1], [@pone.0048168-Stephenson1]. Factors underpinning higher stigma outside of urban areas may include a lack of visibility of HIV prevention initiatives, and thus less dialogue and education regarding HIV, reduced support services, and a lack of privacy and confidentiality [@pone.0048168-Heckman1], [@pone.0048168-Reif1], [@pone.0048168-Stephenson1]. Increased age and education may be associated with internal resources such as self-esteem, coping, life satisfaction, and emotional health, as well as higher income: these factors may mitigate experiences of HIV-related stigma [@pone.0048168-Logie1]. Longer duration of HIV diagnosis--correlated with lower HIV-related stigma--is also associated with older age. People living with HIV may develop coping strategies and social support networks over time to help reduce stigma.

Understanding how racism and sexism may exacerbate HIV-related stigma can inform interventions to challenge stigma. Systematic reviews have underscored a paucity of evidence-based HIV-related stigma reduction interventions [@pone.0048168-Mahajan1], [@pone.0048168-Sengupta1], [@pone.0048168-Brown1]. These reviews recommend multi-level interventions that use a variety of approaches. For example, individual and community interventions to reduce HIV-related stigma can incorporate: counseling and support groups for PLHIV; information and education for non-PLHIV; mass media campaigns; and skills-building for family/friends to improve care for PLHIV [@pone.0048168-Mahajan1], [@pone.0048168-Sengupta1], [@pone.0048168-Brown1], [@pone.0048168-UNAIDS3]. Structural level interventions can include institutional protection from discrimination based on HIV serostatus, race/ethnicity, gender, and sexual orientation, as well as anti-discrimination training for health/social service providers [@pone.0048168-Mahajan1], [@pone.0048168-Brondolo1], [@pone.0048168-Schwartz1]. HIV-related stigma reduction interventions must challenge racist and sexist stereotypes not only in HIV discourse but also in Canadian society in order to benefit women and ethnic minorities--among the most stigmatized PLHIV.

This study had several limitations. The OCS is a voluntary study involving a non-random sampling of PLHIV who are in care and there was a potential for selection bias as the participants in the OCS may differ from the general population of PLHIV in Ontario [@pone.0048168-Rourke1], [@pone.0048168-Raboud1]. It is possible that PLHIV who participate in the OCS experience lower levels of stigma and fewer concerns regarding disclosure of information. Although the sample size for the cohort was significant, the small number of female participants may have limited the determination of significant differences in stigma levels between ethnicity groups. The study was also not able to capture the experiences of transgender PLHIV due to the small number enrolled within the OCS. Small numbers of certain ethnicities such as Asian and Latin American resulted in combining these populations, precluding understanding the similarities/differences in HIV-related stigma within and between these groups. No data was available on pregnancy which may impact stigma experienced by women due to issues of disclosure or if HIV diagnosis occurred during pregnancy.

Our findings suggest the need to move beyond a layered or compounded stigma model. Layered/compounded stigma posits that more marginalized identities result in more cumulative oppression, whereas intersectionality suggests that social identities are multi-dimensional and cannot be summed up [@pone.0048168-Reidpath1], [@pone.0048168-Vanable2], [@pone.0048168-Collins1], [@pone.0048168-Shields1], [@pone.0048168-PurdieVaughns1]. Current findings reveal that certain marginalized identitites, such as gender, may interact with HIV-related stigma to increase stigmatization while others, such as sexual orientation, may reduce experiences of HIV-related stigma. These findings build on conceptualizations of HIV-related stigma that describe racism, sexism, and pre-existing stigma towards drug users and men who have sex with men (MSM) as predisposing facilitators of HIV-related stigma [@pone.0048168-Mahajan1], [@pone.0048168-Sengupta1] to suggest that stigma may additionally be complicated by identity, context, history, and socio-cultural and political factors. Intersectionality therefore affords a more nuanced understanding of stigma that challenges the notion of who may be pre-disposed to stigma.

This situational nature of HIV-related stigma cannot be understated. For example, human rights violations among sexual minorities in multiple countries highlight the importance of understanding context in ascertaining the meaning and significance of sexual orientation in experiences of HIV-related stigma [@pone.0048168-Baral1], [@pone.0048168-Baral2]. HIV has long been constructed as a "gay disease" and an abundance of literature highlights the convergence of HIV-related stigma with sexual stigma and homophobia [@pone.0048168-Swendeman1], [@pone.0048168-Herek4], [@pone.0048168-Baral1]--[@pone.0048168-Crandall1]. This literature serves as a reminder that the current study\'s findings of lower HIV-related stigma among sexual minorities may not be generalizable outstide of urban Canadian settings.

Conclusions {#s5}
===========

In our study, we found that female gender and non-White ethnicity were associated with higher total and subscale HIV-related stigma scores. In our multivariable model, gender and ethnicity interacted to increase the degree of stigma experienced by Black women, Aborginal/Asian/Latin-American/Unspecified men, and Black men. Future research could explore why some marginalized groups may experience lower HIV-related stigma while others experience higher HIV-related stigma. Understanding contextual factors, such as culture, country, and rural/urban differences, is also central to understanding and addressing HIV-related stigma. Additional research should examine the intersection of HIV-related stigma with ethnicity, gender, and sexual orientation at multiple levels (micro, meso and macro) locally, regionally, and globally [@pone.0048168-Logie1], [@pone.0048168-Logie2]. There is a clear need for evidence-based interventions to challenge HIV-related stigma among diverse populations of PLHIV [@pone.0048168-Sengupta1], [@pone.0048168-ScottSheldon1], [@pone.0048168-Simbayi1] at multiple levels. The complexity of HIV-related stigma necessitates engaging with all aspects of PLHIV identity to promote equity and human rights.
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